These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques. Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452 [TBL] [Abstract][Full Text] [Related]
24. Sequence analysis and variation of EBNA-1 in Epstein-Barr virus-related herpesvirus of cynomolgus monkey. Ohara N; Hayashi K; Teramoto N; Oka T; Fujimoto K; Yoshikawa Y; Castanos-Velez E; Biberfeld P; Akagi T Intervirology; 2000; 43(2):102-6. PubMed ID: 10971128 [TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus Macaques. Herrman M; Mühe J; Quink C; Wang F J Virol; 2016 Feb; 90(3):1222-30. PubMed ID: 26559839 [TBL] [Abstract][Full Text] [Related]
26. Macaque homologs of EBV and KSHV show uniquely different associations with simian AIDS-related lymphomas. Bruce AG; Bielefeldt-Ohmann H; Barcy S; Bakke AM; Lewis P; Tsai CC; Murnane RD; Rose TM PLoS Pathog; 2012; 8(10):e1002962. PubMed ID: 23055934 [TBL] [Abstract][Full Text] [Related]
27. Neutralizing antibodies against Epstein-Barr virus infection of B cells can protect from oral viral challenge in the rhesus macaque animal model. Mühe J; Aye PP; Quink C; Eng JY; Engelman K; Reimann KA; Wang F Cell Rep Med; 2021 Jul; 2(7):100352. PubMed ID: 34337567 [TBL] [Abstract][Full Text] [Related]
28. Strong selective pressure for evolution of an Epstein-Barr virus LMP2B homologue in the rhesus lymphocryptovirus. Rivailler P; Quink C; Wang F J Virol; 1999 Oct; 73(10):8867-72. PubMed ID: 10482645 [TBL] [Abstract][Full Text] [Related]
29. Reduced prevalence of Epstein-Barr virus-related lymphocryptovirus infection in sera from a new world primate. Fogg MH; Carville A; Cameron J; Quink C; Wang F J Virol; 2005 Aug; 79(15):10069-72. PubMed ID: 16014968 [TBL] [Abstract][Full Text] [Related]
30. Cloning of the Epstein-Barr virus-related rhesus lymphocryptovirus as a bacterial artificial chromosome: a loss-of-function mutation of the rhBARF1 immune evasion gene. Ohashi M; Orlova N; Quink C; Wang F J Virol; 2011 Feb; 85(3):1330-9. PubMed ID: 21084476 [TBL] [Abstract][Full Text] [Related]
31. Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host. Rivailler P; Carville A; Kaur A; Rao P; Quink C; Kutok JL; Westmoreland S; Klumpp S; Simon M; Aster JC; Wang F Blood; 2004 Sep; 104(5):1482-9. PubMed ID: 15150077 [TBL] [Abstract][Full Text] [Related]
33. Functional analysis of glycoprotein L (gL) from rhesus lymphocryptovirus in Epstein-Barr virus-mediated cell fusion indicates a direct role of gL in gB-induced membrane fusion. Plate AE; Smajlović J; Jardetzky TS; Longnecker R J Virol; 2009 Aug; 83(15):7678-89. PubMed ID: 19457993 [TBL] [Abstract][Full Text] [Related]
34. Lymphocryptovirus Infection of Nonhuman Primate B Cells Converts Destructive into Productive Processing of the Pathogenic CD8 T Cell Epitope in Myelin Oligodendrocyte Glycoprotein. Jagessar SA; Holtman IR; Hofman S; Morandi E; Heijmans N; Laman JD; Gran B; Faber BW; van Kasteren SI; Eggen BJ; 't Hart BA J Immunol; 2016 Aug; 197(4):1074-88. PubMed ID: 27412414 [TBL] [Abstract][Full Text] [Related]
35. Molecular evidence for rhesus lymphocryptovirus infection of epithelial cells in immunosuppressed rhesus macaques. Kutok JL; Klumpp S; Simon M; MacKey JJ; Nguyen V; Middeldorp JM; Aster JC; Wang F J Virol; 2004 Apr; 78(7):3455-61. PubMed ID: 15016868 [TBL] [Abstract][Full Text] [Related]
36. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. Ling PD; Ryon JJ; Hayward SD J Virol; 1993 Jun; 67(6):2990-3003. PubMed ID: 8388484 [TBL] [Abstract][Full Text] [Related]
37. Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus. Lee MA; Diamond ME; Yates JL J Virol; 1999 Apr; 73(4):2974-82. PubMed ID: 10074147 [TBL] [Abstract][Full Text] [Related]
38. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. Cordier M; Calender A; Billaud M; Zimber U; Rousselet G; Pavlish O; Banchereau J; Tursz T; Bornkamm G; Lenoir GM J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588 [TBL] [Abstract][Full Text] [Related]
39. The genomic sequence of lymphocryptovirus from cynomolgus macaque. Kamperschroer C; Gosink MM; Kumpf SW; O'Donnell LM; Tartaro KR Virology; 2016 Jan; 488():28-36. PubMed ID: 26590795 [TBL] [Abstract][Full Text] [Related]
40. Lymphocryptovirus phylogeny and the origins of Epstein-Barr virus. Ehlers B; Spiess K; Leendertz F; Peeters M; Boesch C; Gatherer D; McGeoch DJ J Gen Virol; 2010 Mar; 91(Pt 3):630-42. PubMed ID: 19923263 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]